Pulse Biosciences, Inc. (PLSE)

Pulse Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	80.74	118.04	44.37	61.14	28.61
Cash & Short-Term Investments	80.74	118.04	44.37	61.14	28.61
Cash Growth	-31.60%	166.06%	-27.44%	113.67%	39.75%
Accounts Receivable	0.27	-	-	-	0.06
Inventory	0.14	-	-	-	5.82
Other Current Assets	2.28	1.41	0.96	1.01	2.13
Total Current Assets	83.42	119.45	45.33	62.15	36.63
Net Property, Plant & Equipment	7.06	8.32	8.78	10.02	11.25
Other Intangible Assets	0.58	1.22	1.89	2.55	3.22
Goodwill	2.79	2.79	2.79	2.79	2.79
Other Long-Term Assets	0.69	0.68	0.37	0.37	0.37
Total Assets	94.54	132.46	59.15	77.88	54.25
Accounts Payable	2.78	1.67	1.84	1.57	2.9
Accrued Expenses	3.58	7.03	3.81	2.6	4.39
Short-Term Debt	-	-	-	0.92	0.44
Current Portion of Leases	1.57	1.36	1.06	0.9	0.77
Unearned Revenue	-	-	-	-	0.02
Total Current Liabilities	7.92	10.06	6.71	5.98	8.52
Long-Term Leases	5.96	7.54	8.09	9.14	10.04
Other Long-Term Liabilities	-	-	-	65	-
Total Long-Term Liabilities	5.96	7.54	8.09	74.14	10.04
Total Liabilities	13.88	17.6	14.79	80.13	18.56
Common Stock	0.07	0.07	0.06	0	0.03
Additional Paid-in Capital	543.87	505.3	381.22	292.42	271.86
Retained Earnings	-463.28	-390.5	-336.92	-294.71	-236.2
Shareholders' Equity	80.66	114.86	44.36	-2.25	35.69
Total Liabilities & Equity	94.54	132.46	59.15	77.88	54.25
Total Debt	7.53	8.9	9.14	10.96	11.25
Net Cash (Debt)	73.21	109.14	35.22	50.18	17.36
Net Cash Growth	-32.93%	209.87%	-29.81%	189.00%	90.42%
Net Cash Per Share	1.09	1.87	0.71	1.48	0.62
Book Value	80.66	114.86	44.36	-2.25	35.69
Book Value Per Share	1.20	1.97	0.89	-0.07	1.28
Tangible Book Value	77.29	110.85	39.68	-7.59	29.68
Tangible Book Value Per Share	1.15	1.90	0.80	-0.22	1.06

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q